Streetbeat News

Equity Actions

CNC

HQY

MOH

PGNY

UNH

An analysis of UnitedHealth Group (UNH) compared to its competitors in the Health Care Providers & Services industry reveals potential undervaluation based on its PE ratio, high valuation on assets per PB ratio, and strong profitability indicated by high ROE and EBITDA. Despite these strengths, its revenue growth is slightly lower than the industry average. Competitors analyzed include Centene Corp (CNC), Molina Healthcare Inc (MOH), HealthEquity Inc (HQY), and Progyny Inc (PGNY).

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 3:00 pm

VMC

Vulcan Materials (NYSE:VMC) received mixed analyst ratings with 8 analysts offering insights in the past three months. The average 12-month price target is $266.88, reflecting a 5.85% increase from the previous target. Analysts from firms like Truist Securities, JP Morgan, and Goldman Sachs have raised their price targets, indicating a positive outlook on VMC's performance. Vulcan Materials, a leading producer of construction aggregates in the US, reported a revenue growth rate of 5.91% and a net margin of 12.4%, outperforming industry averages in profitability but facing challenges in asset utilization and financial leverage.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 3:00 pm

AVGO

The analysis compares Broadcom (AVGO) to its competitors in the Semiconductors & Semiconductor Equipment industry, highlighting its financial metrics, market position, and growth prospects. Broadcom, with over $30 billion in annual revenue, sells core semiconductor products and software. It has a lower P/E and P/B ratio than the industry average, suggesting undervaluation, but a higher P/S ratio, indicating potential overvaluation in sales performance. Its ROE is below the industry average, but it has higher EBITDA, gross profit, and revenue growth, showcasing strong financial performance.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 3:00 pm

AMZN

Jeff Bezos convinced his siblings to invest $10,000 each in Amazon in the mid-1990s, which has now grown to be worth $1.30 billion each. This investment showcases the immense growth of Amazon from its early days to a current market cap of $1.86 trillion, highlighting the potential of visionary entrepreneurship in the digital economy.

Portfolio Pulse from Rounak Jain

April 02, 2024 | 2:59 pm

GRTS

Gritstone Bio Inc (NASDAQ:GRTS) released preliminary Phase 2 data for its cancer vaccine GRANITE, showing early benefit trends in metastatic colorectal cancer patients. The study highlighted a 100% vaccine manufacturing success rate and a favorable safety profile. Concurrently, Gritstone priced a $32.5 million public offering and announced a 40% workforce reduction due to a delay in the CORAL Phase 2b study and subsequent loss of anticipated funding. GRTS shares dropped 43% to $1.34.

Portfolio Pulse from Vandana Singh

April 02, 2024 | 2:56 pm

GTLB

GitLab's (NYSE:GTLB) short interest has decreased by 23.99% since the last report, with 3.20 million shares sold short, representing 2.63% of its float. This decline in short interest, which now stands below the peer group average of 4.29%, could indicate a more bullish market sentiment towards GitLab. However, this does not necessarily predict a near-term price increase.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 2:15 pm

ZTS

Zoetis (NYSE:ZTS) received mixed analyst ratings over the past three months, with a recent shift towards more bullish perspectives. The average 12-month price target for ZTS has been raised to $225.25, reflecting a 2.97% increase from the previous target. Analysts from Stifel, Piper Sandler, Barclays, and Goldman Sachs have adjusted their ratings and price targets, indicating a positive outlook on Zoetis's performance. The company, a leader in animal health products, has shown strong financial indicators such as revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio and market capitalization below industry average.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 2:00 pm

MLM

Martin Marietta Materials (NYSE:MLM) received mixed ratings from 10 analysts, with an updated average 12-month price target of $615.5, marking a 15.43% increase from the previous target. Analysts from firms like Truist Securities, JP Morgan, and Goldman Sachs have raised their price targets, reflecting optimism about MLM's financial performance, including a solid revenue growth rate of 8.92% and an impressive net margin of 19.49%. However, the company faces challenges with a high debt-to-equity ratio of 0.59.

Portfolio Pulse from Benzinga Insights

April 02, 2024 | 2:00 pm

VEEV

Veeva Systems announced that Brent Bowman's tenure as CFO and Principal Financial Officer will conclude on April 1, 2024. Tim Cabral, who served as CFO from 2010-2020, will step in as interim CFO and PFO until a successor is appointed, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 02, 2024 | 1:29 pm

AAPL

AMZN

META

SPY

The S&P 500 recorded a 10.6% return in Q1 2024, marking its second consecutive quarter of double-digit gains, a historic signal of bullish trends. The SPDR S&P 500 ETF (SPY) mirrored these gains. Factors contributing to this rally include a shift in the yield curve and economic resilience, despite a more hawkish monetary policy than expected. S&P 500 earnings rose by 4.1% year-on-year in Q4 2023, with significant growth in communications, consumer discretionary, technology, and utilities sectors. The upcoming earnings season is anticipated to show continued growth, with a 3.4% increase in EPS expected.

Portfolio Pulse from Neil Dennis

April 02, 2024 | 1:23 pm